跳至主要内容
临床试验/NCT06038110
NCT06038110进行中(未招募)不适用

Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era: A Retrospective Cohort Study

KK Women's and Children's Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
150
试验地点
1
主要终点
the number of abnormal nodes on ultrasound

研究概览

简要总结

The investigators aimed to determine if axillary ultrasound can reliably distinguish between patients with limited or high nodal burden, so that the patients with limited nodal burden can potentially avoid chemotherapy and instead receive upfront surgery followed by gene assay testing.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
21 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • breast cancer patients with T1-3, HR-positive and HER2-negative disease.
  • aged≥ 50 years old
  • had axillary ultrasound prior to operation
  • axillary lymph node dissection

排除标准

  • Patients with neoadjuvant chemotherapy
  • bilateral cancers

结局指标

主要结局

the number of abnormal nodes on ultrasound

时间窗: from the date of diagnosis to the date of surgery, up to 12 weeks

the number of abnormal nodes on ultrasound which was done at the time of diagnosis will be measured

次要结局

未报告次要终点

研究者

发起方
KK Women's and Children's Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Use of Axillary Ultrasound to Guide Breast Cancer... | 临床试验